ESCAVITE D- .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol, dl-, thiamine hydrochloride, riboflavin, niacin, pyridoxine hydrochloride, folic acid, hydroxocobalamin, biotin, calcium pantothenate, ferrous cysteine glycinate, magnesium oxide, zinc oxide, cupric oxide, and sodium fluoride tablet, chewable 
GM Pharmaceuticals, INC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Escavite D

Description: Escavite® D is a prescription drug multi-vitamin chewable tablet with Iron and Fluoride 0.25 mg. Escavite® D chewable tablets are dye free, off-white speckled, round shaped, cherry-flavored tablets, and are debossed with E on one side and plain on the other.

Each chewable tablet contains:

Vitamin A (as beta carotene)…………………………………………………. 2,500 IU

Vitamin C (as ascorbic acid)……………………………………………………100 mg

Vitamin D (as cholecalciferol)………………………………………………….600 IU

Vitamin E (as dl-alpha tocopheryl acetate)…………………………………….30 IU

Thiamine (as thiamine HCl, vitamin B1)……………………………………….1.5 mg

Riboflavin………………………………………………………………………1.7 mg

Niacin (as niacinamide)………………………………………………………….20 mg

Vitamin B6 (as pyridoxine HCl)………………………………………………….2 mg

Folic Acid, USP as CitraFolic®a [from controlled-release Citrated-pteroylmonoglutamic Acid] 400 mcg

Vitamin B12 (as hydroxocobalamin)……………………………………………6 mcg

Biotin…………………………………………………………………………...45 mcg

Pantothenic Acid (as d-calcium pantothenate)………………………………….10 mg

Iron (elemental) as AminoFerr® b [from ferrous  glycine cysteinate] and ferric pyrophosphate 6 mg

Magnesium (as magnesium oxide)………………………………………………60 mg

Zinc (as zinc chelate)…………………………………………………………….15 mg

Copper (as copper chelate)………………………………………………………..2 mg

Fluoride (as sodium fluoride)………………………………………………….0.25 mg

Ingredient for caries prophylaxis: *Fluoride as sodium fluoride. Other Ingredients: Sucrose, Xylitol, Sunflower Oil, Microcrystalline Cellulose, Sucralose, Natural Cherry Flavor, Stearic Acid, Magnesium Stearate, Fumed Silica, and Silicon Dioxide.

aCitraFolic® is a controlled-release form of folic acid that is pH-specific using citrates as buffers to achieve optimal absorption for targeted-GI at the proximal jejunum AND in order to meet USP requirements for folic acid dissolution and disintegration; it is patent pending. CitraFolic® uses only DMF-approved manufacturers of folic acid.

bAminoFerr® as ferrous glycine cysteinate, also known as FERROUS CYSTEINE GLYCINATE, and has the Unique Ingredient Identifier (UNII) code 8B4OP7RK5N. AminoFerr® is a proprietary ingredient containing pure chelates without interfering ions –resulting in high solubility and adsorption; it is the only pure amino acid iron chelate supplement on the market, and is protected under US Patent No. 7,341,708.

ESCAVITE® D

PRESCRIPTION DRUG MULTI-VITAMIN WITH IRON AND

FLUORIDE 0.25 mg CHEWABLE TABLETS

Rx Only

CLINICAL PHARMACOLOGY

It is well established that fluoridation of the water supply (1 ppm fluoride) during period of tooth development leads to a significant decrease in the incidence of dental caries. Escavite® D Multi-vitamin with Iron and Fluoride Chewable Tablets provide sodium fluoride, magnesium, zinc, copper, twelve essential vitamins, and iron in a chewable tablet. Because tablets are chewable, they provide a topical as well as systemic source of fluoride.

Hydroxyapatite is the principal crystal for all calcified tissue in the human body. The fluoride ion reacts with the hydroxyapatite in the tooth as it is formed to produce the more caries-resistant crystal fluorapatite. The reaction may be expressed by the equation:

Ca10(PO4)6(OH)2 + 2F- ¦Ca10(PO4)F2 + 2OH –
(Hydroxyapatite) (Fluorapatite)

Three stages of fluoride deposition in tooth enamel can be distinguished:

1. Small amounts (reflecting the low levels of fluoride in tissue fluids) are incorporated into the enamel crystals while they are being formed.

2. After enamel has been laid down, fluoride deposition continues in the surface enamel. Diffusion of fluoride from the surface inward is apparently restricted.

3. After eruption, the surface enamel acquires fluoride from water, food supplementary fluoride and smaller amounts from saliva.

INDICATIONS AND USAGE

Escavite® D Multi-vitamin with Iron and Fluoride Chewable Tablets is a prescription drug product for the dietary management of the metabolic processes of caries prophylaxis, and provides supplementation of the diet with twelve essential vitamins, magnesium, zinc, copper and iron.

Escavite® D Multi-vitamin with Iron and Fluoride Chewable Tablets provide 0.25 mg of fluoride in a chewable tablet form for children 4-6 years of age where the drinking water contains 0.3 through 0.6 ppm of fluoride. Escavite® D Multi-vitamin with Iron and Fluoride Chewable Tablets supply significant amounts of Vitamins A, C, D, E, thiamine, riboflavin, niacin, Vitamin B6, folate, vitamin B12, biotin, pantothenic acid, to supplement the diet, and to help assure that nutritional deficiencies of these vitamins will not develop. Thus, in a single easy-to-use preparation, children obtain twelve essential vitamins and the important minerals, magnesium, zinc, copper, iron and fluoride. The American Academy of Pediatrics recommends that children up to the age of 16, in areas where drinking water contains less than optimal levels of fluoride, receive daily fluoride supplementation. Children using Escavite® D Multi-vitamin with Iron and Fluoride Chewable Tablets regularly should receive semiannual dental examinations. The regular brushing of teeth and attention to good oral hygiene practices are also essential.

CONTRAINDICATIONS

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING:

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdosage, call a doctor or a poison control center immediately.

PRECAUTIONS

The suggested dose of Escavite® D Multi-vitamin with Iron and Fluoride Chewable Tablets should not be exceeded, since dental fluorosis may result from continued ingestion of large amounts of fluoride.

Before prescribing Escavite® D Multi-vitamin with Iron and Fluoride Chewable Tablets:

1. Determine the fluoride content of the drinking water from all major sources.

2. Make sure the child is not receiving significant amounts of fluoride from other sources such as medications and swallowed toothpaste.

3. Periodically check to make sure that the child does not develop significant dental fluorosis.

Your doctor or dentist is the best source of counsel and guidance in your child's fluoride supplementation.

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

DRUG INTERACTIONS

Do not eat or drink dairy products within one hour of fluoride administration. Incompatibility of fluoride with dairy foods has been reported due to formation of calcium fluoride which is poorly absorbed.

ADVERSE REACTIONS

Allergic rash and other idiosyncrasies have been rarely reported. To report adverse side effects or to obtain product information, contact GM Pharmaceuticals at 1-888-535-0305.

OVERDOSAGE:

Prolonged daily ingestion of excessive fluoride will result in varying degrees of Fluorosis.

DOSAGE AND ADMINISTRATION

Chew one tablet daily or as prescribed by doctor, or dentist. Tablets should be chewed or crushed before they are swallowed. This product is not recommended for children under age 4 due to risk of choking.

HOW SUPPLIED

They are available in bottles of 60 chewable tablets (NDC 58809-829-60) and 1 count physician samples (NDC 58809-829-02).

STORAGE

Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F). See USP Controlled Room Temperature. Protect from light and moisture. Dispense in a tight, light-resistant container with a child-resistant closure as defined in the USP/NF.

KEEP OUT OF REACH OF CHILDREN

REFERENCES

1. Brudevoid F, McCann HG: Fluoride and caries control - Mechanism of action, in Nizel AE, Ed: The Science of Nutrition and its Application in Clinical Dentistry. Philadelphia, WB Saunders Company, 1966, pp 331-347.

2. American Academy of Pediatrics, Committee on Nutrition: Fluoride Supplementation for Children: Interim Policy Recommendations. Pediatrics. 1995; 95 (5):777.

3. American Dental Association Council on Dental Therapeutics. New Fluoride Schedule Adopted. ADA News. May 16, 1994; 12-14.

Manufactured for:

GM Pharmaceuticals, Inc.

Arlington, TX 76015

Made in Canada

Covered by US Patent No. 7,341,708

Patent Pending.

R010216-1

PRINCIPAL DISPLAY PANEL

NDC 58809-829-60
ESCAVITE D
Prescription Multi-Vitamin
With Iron and Fluoride
0.25 mg
Cherry Flavored
Chewable Tablets
60 Tablets
Rx Only

PRINCIPAL DISPLAY PANEL
NDC 58809-829-60
ESCAVITE D
Prescription Multi-Vitamin 
With Iron and Fluoride 
0.25 mg
Cherry Flavored
Chewable Tablets
60 Tablets
Rx Only

PRINCIPAL DISPLAY PANEL
NDC 58809-829-60
ESCAVITE D
Prescription Multi-Vitamin 
With Iron and Fluoride 
0.25 mg
Cherry Flavored
Chewable Tablets
60 Tablets
Rx Only

PRINCIPAL DISPLAY PANEL
NDC 58809-829-60
ESCAVITE D
Prescription Multi-Vitamin 
With Iron and Fluoride 
0.25 mg
Cherry Flavored
Chewable Tablets
60 Tablets
Rx Only

ESCAVITE D 
.beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol, dl-, thiamine hydrochloride, riboflavin, niacin, pyridoxine hydrochloride, folic acid, hydroxocobalamin, biotin, calcium pantothenate, ferrous cysteine glycinate, magnesium oxide, zinc oxide, cupric oxide, and sodium fluoride tablet, chewable
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:58809-829
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
.BETA.-CAROTENE (UNII: 01YAE03M7J) (.BETA.-CAROTENE - UNII:01YAE03M7J) .BETA.-CAROTENE2500 [iU]
ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID100 mg
CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL600 [iU]
.ALPHA.-TOCOPHEROL, DL- (UNII: 7QWA1RIO01) (.ALPHA.-TOCOPHEROL, DL- - UNII:7QWA1RIO01) .ALPHA.-TOCOPHEROL, DL-30 [iU]
THIAMINE HYDROCHLORIDE (UNII: M572600E5P) (Thiamine ION - UNII:4ABT0J945J) THIAMINE HYDROCHLORIDE1.5 mg
RIBOFLAVIN (UNII: TLM2976OFR) (RIBOFLAVIN - UNII:TLM2976OFR) RIBOFLAVIN1.7 mg
NIACIN (UNII: 2679MF687A) (NIACIN - UNII:2679MF687A) NIACIN20 mg
PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE HYDROCHLORIDE2 mg
FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID400 ug
HYDROXOCOBALAMIN (UNII: Q40X8H422O) (HYDROXOCOBALAMIN - UNII:Q40X8H422O) HYDROXOCOBALAMIN6 ug
BIOTIN (UNII: 6SO6U10H04) (BIOTIN - UNII:6SO6U10H04) BIOTIN45 ug
CALCIUM PANTOTHENATE (UNII: 568ET80C3D) (PANTOTHENIC ACID - UNII:19F5HK2737, CALCIUM CATION - UNII:2M83C4R6ZB) PANTOTHENIC ACID10 mg
FERROUS CYSTEINE GLYCINATE (UNII: 8B4OP7RK5N) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION6 mg
MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM OXIDE60 mg
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE15 mg
CUPRIC OXIDE (UNII: V1XJQ704R4) (CUPRIC CATION - UNII:8CBV67279L) CUPRIC CATION2 mg
SODIUM FLUORIDE (UNII: 8ZYQ1474W7) (FLUORIDE ION - UNII:Q80VPU408O) FLUORIDE ION0.25 mg
Inactive Ingredients
Ingredient NameStrength
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
CHERRY (UNII: BUC5I9595W)  
DEXTROSE (UNII: IY9XDZ35W2)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
SORBITOL (UNII: 506T60A25R)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
XYLITOL (UNII: VCQ006KQ1E)  
Product Characteristics
ColorWHITE (off-white, speckled) Scoreno score
ShapeROUNDSize16mm
FlavorImprint Code E
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58809-829-6060 in 1 BOTTLE; Type 0: Not a Combination Product03/03/201411/01/2018
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
UNAPPROVED DRUG OTHER03/03/201411/01/2018
Labeler - GM Pharmaceuticals, INC (793000860)

Revised: 11/2019
 
GM Pharmaceuticals, INC